CLDN4 as a Novel Diagnostic and Prognostic Biomarker and Its Association with Immune Infiltrates in Ovarian Cancer

Figure 7

(a, b) Relationships between CLDN4 expression and infiltrating immune cells in OC.

(a)

(b)